Comparative efficacy of placebos in short-term antidepressant trials for major depression: a secondary meta-analysis of placebo-controlled trials
Abstract Background The issue of unblinded outcome-assessors and patients has repeatedly been stressed as a flaw in allegedly double-blind antidepressant trials. Unblinding bias can for example result from a drug‘s marked side effects. If such unblinding bias is present for a given drug, then it mig...
Main Authors: | Lisa Holper, Michael P. Hengartner |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | BMC Psychiatry |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12888-020-02839-y |
Similar Items
-
Challenging Received Wisdom: Antidepressants and the Placebo Effect
by: Irving Kirsch
Published: (2020-12-01) -
Neural Predictors of the Antidepressant Placebo Response
by: Danielle Rette, et al.
Published: (2019-10-01) -
Significance of Participants’ Expectations in Managing the Placebo Effect in Antidepressant Research
by: Marko Curkovic, et al.
Published: (2019-10-01) -
Neuroimaging Studies of Antidepressant Placebo Effects: Challenges and Opportunities
by: Vanessa Brown, et al.
Published: (2019-09-01) -
Placebo Responses and Their Clinical Implications in Fibromyalgia: A Meta-Analysis Using SSRI and SNRI Trials
by: Helen Koechlin, et al.
Published: (2021-12-01)